Epstein Secrets

w corporate headquarters in Waltham, MA, IMDx today announced its third FDA clearance for its C. difficile assay for Abbott m2000 assay. My best, Alice IntelligentMDx Receives FDA Clearance for IMDx C. difficile for Abbott m2000 Assay, Completes Move of Corporate Headquarters to Waltham WALTHAM, M

From: Alice Jacobs Nesselrodt :< => To: Alice Jacobs Nesselrodt Subject: IMDx receives 3rd FDA clearance and relocates HQ to Waltham Date: Tue, 12 Nov 2013 21:14:41 +0000 Atta

d are responsible for a variety of healthcare- associated infections, including surgical wound, urinary tract, and bloodstream infections. My best, Alice IntelligentMDx Receives FDA Clearance for IMDx VanR for Abbott m2000 assay Cambridge, MA, July 29, 2013 — IntelligentMDx (privately held) announced

t IMDx can offer a diagnostic solution to aid in the identification of vancomycin-resistant colonization in hospital settings in the U.S.," says Dr. Alice Jacobs Nesselrodt, Chairman and CEO of IMDx. "FDA clearance of the IMDx VanR for Abbott m2000 assay is a step toward the fulfillment of IMDx's mission to make clinic

rom: Matthew Copeland Sent: Monday, October 07, 2013 10:49 AM To: Alice Jacobs Nesselrodt; Sarah Toomey Cc: Joseph Shipman Subject: RE: Boris Hi Alice, Attached is a copy of Boris's common stock certificate and conversion from =LC to Inc. certificate (provided by Joe). 2 EFTA_R1_02107005 EFTA027

This is in addition to other 500K. Please let's discuss when we meet next week. Can't wait to see you! Thank you Boris Original Message From: Alice Jacobs Nesselrodt Sent: Thursday, October 17, 2013 7:50 AM To: Boris Nikolic Subject: FW: Boris Some additional info Alice Jacobs Nesselrodt, M.D. Chairman & CEO